Journal Home > Volume 15 , Issue 2

Currently, chemotherapy is the main clinical therapy of tumors. Depressingly, most chemotherapeutic drugs such as doxorubicin and paclitaxel (PTX) have poor water solubility, leading to low bioavailability and serious side effects. Till now, although a variety of nanoparticulate drug delivery systems have been designed to ameliorate the above disadvantage of chemotherapy drugs, their application is still severely limited due to the complex preparation, poor stability, low drug loading, and premature drug release. Herein, a metal phenolic network-based drug delivery system with superior stability, satisfactory drug loading capacity, good biocompatibility, reduced undesired premature release, and excellent anti-tumor ability has been established for achieving step-by-step multiple stimuli-responsive drug delivery. Firstly, the redox-responsive dimeric paclitaxel (diPTX) prodrug was synthesized. Then diPTX@Fe & tannic acid (diPTX@Fe&TA) complex nanoparticles with satisfactory PTX loading capacity were obtained by deposition of Fe&TA network complex on the nanocore of diPTX rapidly with a simple method. The diPTX@Fe&TA nanoparticles have a hydrodynamic diameter of 152.6 ± 1.2 nm, long-term colloidal stability, and high PTX loading content of 24.7%. Besides, diPTX@Fe&TA could expose to the acidic lysosomal environment and the reduction cytoplasmic environment continuously, resulting in the sequential release of diPTX and PTX when it was phagocytosed by tumor cells. Meanwhile, PTX showed almost no release under physiological condition (pH 7.4), which effectively inhibited the undesirable premature release of PTX. More importantly, diPTX@Fe&TA could suppress the growth of tumor effectively in vivo, along with negligible toxicity for organs. This work developed a simple and novel approach for the construction of a stepwise multiple stimuli-responsive drug delivery system with superior stability and satisfactory drug loading capacity to inhibit tumor growth effectively.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

A step-by-step multiple stimuli-responsive metal-phenolic network prodrug nanoparticles for chemotherapy

Show Author's information Xiaoqing Yi1Weijia Zeng1Cui Wang1Ying Chen1Liangyuan Zheng1Xinlin Zhu1Yuqiu Ke2Xiaoyan He3( )Ying Kuang1( )Qitong Huang1( )
Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases Ministry of EducationKey Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi ProvinceGannan Medical UniversityGanzhou 341000 China
Faculty of Materials Metallurgy and Chemistry Jiangxi University of Science and TechnologyGanzhou 341000 China
School of Life Sciences Anhui Medical UniversityHefei 230032 China

Abstract

Currently, chemotherapy is the main clinical therapy of tumors. Depressingly, most chemotherapeutic drugs such as doxorubicin and paclitaxel (PTX) have poor water solubility, leading to low bioavailability and serious side effects. Till now, although a variety of nanoparticulate drug delivery systems have been designed to ameliorate the above disadvantage of chemotherapy drugs, their application is still severely limited due to the complex preparation, poor stability, low drug loading, and premature drug release. Herein, a metal phenolic network-based drug delivery system with superior stability, satisfactory drug loading capacity, good biocompatibility, reduced undesired premature release, and excellent anti-tumor ability has been established for achieving step-by-step multiple stimuli-responsive drug delivery. Firstly, the redox-responsive dimeric paclitaxel (diPTX) prodrug was synthesized. Then diPTX@Fe & tannic acid (diPTX@Fe&TA) complex nanoparticles with satisfactory PTX loading capacity were obtained by deposition of Fe&TA network complex on the nanocore of diPTX rapidly with a simple method. The diPTX@Fe&TA nanoparticles have a hydrodynamic diameter of 152.6 ± 1.2 nm, long-term colloidal stability, and high PTX loading content of 24.7%. Besides, diPTX@Fe&TA could expose to the acidic lysosomal environment and the reduction cytoplasmic environment continuously, resulting in the sequential release of diPTX and PTX when it was phagocytosed by tumor cells. Meanwhile, PTX showed almost no release under physiological condition (pH 7.4), which effectively inhibited the undesirable premature release of PTX. More importantly, diPTX@Fe&TA could suppress the growth of tumor effectively in vivo, along with negligible toxicity for organs. This work developed a simple and novel approach for the construction of a stepwise multiple stimuli-responsive drug delivery system with superior stability and satisfactory drug loading capacity to inhibit tumor growth effectively.

Keywords: drug delivery, step-by-step multiple stimuli-responsive, metal-phenolic network, superior stability

References(42)

1

Lu, Y.; Aimetti, A. A.; Langer, R.; Gu, Z. Bioresponsive materials. Nat. Rev. Mater. 2017, 2, 22897–22914.

2

Hossen, S.; Hossain, M. K.; Basher, M. K.; Mia, M. N. H.; Rahman, M. T.; Uddin, M. J. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. J. Adv. Res. 2019, 15, 1–18.

3

van der Meel, R.; Sulheim, E.; Shi, Y.; Kiessling, F.; Mulder, W. J. M.; Lammers, T. Smart cancer nanomedicine. Nat. Nanotechnol. 2019, 14, 1007–1017.

4

Huang, H.; Yang, X. R.; Li, H. L.; Lu, H. S.; Oswald, J.; Liu, Y. M.; Zeng, J.; Jin, C. H.; Peng, X. C.; Liu, J. Y. et al. iRGD decorated liposomes: A novel actively penetrating topical ocular drug delivery strategy. Nano Res. 2020, 13, 3105–3109.

5

Yang, J.; Wang, C.; Shi, S.; Dong, C. Nanotechnologies for enhancing cancer immunotherapy. Nano Res. 2020, 13, 2595–2616. .

6

Poon, W.; Kingston, B. R.; Ouyang, B.; Ngo, W.; Chan, W. C. W. A framework for designing delivery systems. Nat. Nanotechnol. 2020, 15, 819–829.

7

Xu, L.; Zhao, Y. L; Owusu, K. A.; Zhuang, Z. C; Liu, Q.; Wang, Z. Y; Li, Z.; Mai, L. Recent advances in nanowire-biosystem interfaces: From chemical conversion, energy production to electrophysiology. Chem 2018, 4, 1538–1559.

8

Lin, L. S.; Song, J. B.; Song, L.; Ke, K. M; Liu, Y. J.; Zhou, Z. J.; Shen, Z. Y.; Li, J.; Yang, Z.; Tang, W. et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew. Chem. , Int. Ed. 2018, 57, 4902–4906.

9

Lin, G.; Zhang, Y.; Zhang, L.; Wang, J. Q.; Tian, Y.; Cai, W.; Tang, S. G.; Chu, C. C.; Zhou, J. J.; Mi, P. et al. Metal-organic frameworks nanoswitch: Toward photo-controllable endo/lysosomal rupture and release for enhanced cancer RNA interference. Nano Res. 2020, 13, 238–245.

10

Chen, H.; Li, X.; Huo, M. F.; Wang, L. Y.; Chen, Y.; Chen, W.; Wang, B L. . Tumor-responsive copper-activated disulfiram for synergetic nanocatalytic tumor therapy. Nano Res. 2021, 14, 205–211.

11

Horcajada, P.; Chalati, T.; Serre, C.; Gillet, B.; Sebrie, C.; Baati, T.; Eubank, J. F.; Heurtaux, D.; Clayette, P.; Kreuz, C. et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 2010, 9, 172–178.

12

Ke, W. D.; Li, J. J.; Mohammed, F.; Wang, Y. H.; Tou, K.; Liu, X. Y.; Wen, P. Y.; Kinoh, H.; Anraku, Y.; Chen, H. B. et al. Therapeutic polymersome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy. ACS Nano 2019, 13, 2357–2369.

13

He, H. S.; Lu, Y.; Qi, J. P.; Zhu, Q. G.; Chen, Z. J.; Wu, W. Adapting liposomes for oral drug delivery. Acta Pharm. Sin. B 2019, 9, 36–48.

14

Jiang, T. Y.; Xu, G.; Chen, G. J.; Zheng, Y.; He, B. F.; Gu, Z. Progress in transdermal drug delivery systems for cancer therapy. Nano Res. 2020, 13, 1810–1824.

15

Chen, Y. L.; Cheng, K. Advances of biological-camouflaged nano-particles delivery system. Nano Res. 2020, 13, 2617–2624.

16

Gao, C. Y.; Wang, Y.; Ye, Z. H.; Lin, Z. H.; Ma, X.; He, Q. Biomedical micro-/nanomotors: From overcoming biological barriers to in vivo imaging. Adv. Mater. 2021, 33, 2000512.

17

Zhai, S. D.; Hu, X. L.; Hu, Y. J.; Wu, B. Y.; Xing, D. Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy. Biomaterials 2017, 121, 41–54.

18

Yi, X. Q.; Dai, J.; Han, Y. Y.; Xu, M.; Zhang, X. J; Zhen, S. J.; Zhao, Z. J; Lou, X. D.; Xia, F. A high therapeutic efficacy of polymeric prodrug nano-assembly for a combination of photodynamic therapy and chemotherapy. Commun. Biol. 2018, 1, 202.

19

Jia, Y. P.; Song, Y.; Qu, Y.; Peng, J. R.; Shi, K.; Du, D.; Li, H.; Lin, Y. H.; Qian, Z. Y. Mesoporous PtPd nanoparticles for ligand-mediated and imaging-guided chemo-photothermal therapy of breast cancer. Nano Res. 2020, 13, 1739–1748.

20

Yi, X. Q.; Hu, J. J.; Dai, J.; Lou, X. D.; Zhao, Z. J.; Xia, F.; Tang, B. Z. Self-guiding polymeric prodrug micelles with two aggregation-induced emission photosensitizers for enhanced chemo-photodynamic therapy. ACS Nano 2021, 15, 3026–3037.

21

Chen, T.; Su, L. C.; Ge, X. G.; Zhang, W, M.; Li, Q. Q.; Zhang, X.; Ye, J. M.; Lin, L. S.; Song, J. B.; Yang, H. H. Dual activated NIR-Ⅱ fluorescence and photoacoustic imaging-guided cancer chemo-radiotherapy using hybrid plasmonic-fluorescent assemblies. Nano Res. 2020, 13, 3268–3277.

22

Cai, K. M.; He, X.; Song, Z. Y.; Yin, Q.; Zhang, Y. F.; Uckun, F. M.; Jiang, C.; Cheng, J. J. Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. J. Am. Chem. Soc. 2015, 137, 3458–3461.

23

Su, L.; Li, R. C.; Khan, S.; Clanton, R.; Zhang, F. W.; Lin, Y. N.; Song, Y.; Wang, H.; Fan, J. W.; Hernandez, S. et al. Chemical design of both a glutathione-sensitive dimeric drug guest and a glucose-derived nanocarrier host to achieve enhanced osteosarcoma lung metastatic anticancer selectivity. J. Am. Chem. Soc. 2018, 140, 1438–1446.

24

Lin, C. C.; Tong, F.; Liu, R.; Xie, R.; Lei, T.; Chen, Y. X.; Yang, Z. H.; Gao, H. L.; Yu, X. R. GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy. Acta Pharm. Sin. B 2020, 10, 2348–2361.

25

Liu, R.; Yu, M. N.; Yang, X. T.; Umeshappa, C. S.; Hu, C.; Yu, W. Q.; Qin, L.; Huang, Y.; Gao, H L. . Linear chimeric triblock molecules self-assembled micelles with controllably transformable property to enhance tumor retention for chemo-photodynamic therapy of breast cancer. Adv. Funct. Mater. 2019, 29, 1808462.

26

Yang, X. T.; Hu, C.; Tong, F.; Liu, R.; Zhou, Y.; Qin, L.; Ouyang, L.; Gao, H L. Tumor microenvironment-responsive dual drug dimer-loaded PEGylated bilirubin nanoparticles for improved drug delivery and enhanced immune-chemotherapy of breast cancer. Adv. Funct. Mater. 2019, 29, 1901896.

27

Zhang, R. J.; Chen, J.; Mao, L. Z.; Guo, Y. J.; Hao, Y. T.; Deng, Y. D.; Han, X.; Li, Q. J.; Liao, W. Z.; Yuan, M. M. Nobiletin triggers reactive oxygen species-mediated pyroptosis through regulating autophagy in ovarian cancer cells. J. Agric. Food Chem. 2020, 68, 1326–1336.

28

Li, K.; Xiao, G.; Richardson, J. J.; Tardy, B. L.; Ejima, H.; Huang, W.; Guo, J. L.; Liao, X. P.; Shi, B. Targeted therapy against metastatic melanoma based on self-assembled metal-phenolic nanocomplexes comprised of green tea catechin. Adv. Sci. 2019, 6, 1801688.

29

Liu, T.; Zhang, M. K.; Liu, W. L.; Zeng, X.; Song, X. L.; Yang, X. Q.; Zhang, X. Z.; Feng, J. Metal ion/tannic acid assembly as a versatile photothermal platform in engineering multimodal nanotheranostics for advanced applications. ACS Nano 2018, 12, 3917–3927.

30

Ejima, H.; Richardson, J. J.; Liang, K.; Best, J. P.; van Koeverden, M. P.; Such, G. K.; Cui, J. W.; Caruso, F. One-step assembly of coordination complexes for versatile film and particle engineering. Science 2013, 341, 154–157.

31

Guo, J. L; Ping, Y.; Ejima, H.; Alt, K.; Meissner, M.; Richardson, J. J.; Yan, Y.; Peter, K.; von Elverfeldt, D.; Hagemeyer, C. E. et al. Engineering multifunctional capsules through the assembly of metal-phenolic networks. Angew. Chem. , Int. Edit. 2014, 53, 5546–5551.

32

Shen, G. Z.; Xing, R. R.; Zhang, N.; Chen, C. J.; Ma, G. H.; Yan, X H. Interfacial cohesion and assembly of bioadhesive molecules for design of long-term stable hydrophobic nanodrugs toward effective anticancer therapy. ACS Nano 2016, 10, 5720–5729.

33

Yang, B.; Zhou, S.; Zeng, J.; Zhang, L. P.; Zhang, R. H.; Liang, K.; Xie, L.; Shao, B.; Song, S. L.; Huang, G. et al. Super-assembled core–shell mesoporous silica-metal-phenolic network nanoparticles for combinatorial photothermal therapy and chemotherapy. Nano Res. 2020, 13, 1013–1019.

34

Liang, H. S.; Li, J.; He, Y.; Xu, W.; Liu, S. L.; Li, Y.; Chen, Y. J; Li, B. Engineering multifunctional films based on metal-phenolic networks for rational pH-responsive delivery and cell imaging. ACS Biomater. Sci. Eng. 2016, 2, 317–325.

35

Kim, S.; Philippot, S.; Fontanay, S.; Duval, R. E.; Lamouroux, E.; Canilho, N.; Pasc, A. pH- and glutathione-responsive release of curcumin from mesoporous silica nanoparticles coated using tannic acid–Fe(Ⅲ) complex. RSC Adv. 2015, 5, 90550–90558.

36

Abouelmagd, S. A.; Abd Ellah, N. H.; Amen, O.; Abdelmoez, A.; Mohamed, N. G. Self-assembled tannic acid complexes for pH-responsive delivery of antibiotics: Role of drug-carrier interactions. Int. J. Pharm. 2019, 562, 76–85.

37

Meng, X. Y.; Chen, L. Z.; Lv, R. M.; Liu, M.; He, N. Y.; Wang, Z F. A metal-phenolic network-based multifunctional nanocomposite with pH-responsive ROS generation and drug release for synergistic chemodynamic/photothermal/chemo-therapy. J. Mat. Chem. B 2020, 8, 2177–2188.

38

Nichols, J. W.; Bae, Y. H. EPR: Evidence and fallacy. J. Control. Release 2014, 190, 451–464.

39

Yin, S. P.; Huai, J.; Chen, X.; Yang, Y.; Zhang, X. X.; Gan, Y.; Wang, G. J; Gu, X. C; Li, J. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Acta Biomater. 2015, 26, 274–285. .

40

Zhang, Y. R.; Wang, J. N.; Xiao, J. Y.; Fang, T. L.; Hu, N.; Li, M. H.; Deng, L. F.; Cheng, Y. S.; Zhu, Y. Q.; Cui, W. G. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention. Acta Biomater. 2019, 94, 295–305.

41

Zhen, S. J.; Wang, S. W.; Li, S. W.; Luo, W. W.; Gao, M.; Ng, L. G.; Goh, C. C.; Qin, A. J.; Zhao, Z. J.; Liu, B. et al. Efficient red/ near-infrared fluorophores based on benzo[1, 2-b: 4, 5-b']Dithiophene 1, 1, 5, 5-Tetraoxide for targeted photodynamic therapy and in vivo two-photon fluorescence bioimaging. Adv. Funct. Mater. 2018, 28, 1706945.

42

Perry, J. L.; Reuter, K. G.; Luft, J. C.; Pecot, C. V.; Zamboni, W.; DeSimone, J. M. Mediating passive tumor accumulation through particle size, tumor type, and location. Nano Lett. 2017, 17, 2879–2886.

File
12274_2021_3626_MOESM1_ESM.pdf (4 MB)
Publication history
Copyright
Acknowledgements

Publication history

Received: 02 May 2021
Revised: 25 May 2021
Accepted: 26 May 2021
Published: 27 July 2021
Issue date: February 2022

Copyright

© Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature 2021

Acknowledgements

Acknowledgements

This research was supported by the National Natural Science Foundation of China (Nos. 82060599 and 52003006), the Open Project of Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education (No. XN201911), the Natural Science Foundation of Jiangxi Province (No. 20202BABL213018), the Science and Technology Project of the Education Department of Jiangxi Province (Nos. GJJ190795 and GJJ190827), the Research Fund of Gannan Medical University (Nos. QD201903, QD201912, ZD201901, YQ202003, and QD201825), and Undergraduate Science and Technology Innovation Project of Gannan Medical University (No. BKSZR201903).

Return